|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.66 SEK | +1.49% |
|
-4.54% | -21.86% |
| 07-20 | SynAct Pharma Draws SEK50 Million from New Financing Facility | MT |
| 07-20 | Synact Pharma secures access to financing of up to €9.0m | FW |
| Market Cap | 974M 100M 88.03M 82.17M 75.41M 141M 9.6B 145M 381M 4.75B 376M 368M 16.42B | P/E 2026 * |
-11.7x | P/E 2027 * | -22.9x |
|---|---|---|---|---|---|
| Enterprise Value | 957M 98.38M 86.45M 80.69M 74.06M 139M 9.42B 142M 374M 4.66B 369M 361M 16.12B | EV / Sales 2026 * |
6.9x | EV / Sales 2027 * | 47.2x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | +1.49% | ||
| 1 week | -4.54% | ||
| Current month | -16.10% | ||
| 1 month | -16.10% | ||
| 3 months | +0.46% | ||
| 6 months | -14.89% | ||
| Current year | -21.86% |
| 1 week | 17.08 |  | 18.98 |
| 1 month | 17.08 | | 23.5 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.8 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 01/01/2014 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 01/03/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 20/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 20/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 20/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/10/26 A | Buy | Chairman | 2,750 | 0.0052% | ||
| 3/9/26 A | Quantass ApS
| Buy | Company | 7,900 | 0.0148% | |
| 3/9/26 A | Buy | Executive/Senior Manager | 1,500 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.49% | -4.54% | -19.73% | -80.64% | 100M | |
| -0.87% | +4.04% | +58.60% | +163.92% | 1,079B | |
| -0.45% | +3.87% | +57.95% | +52.18% | 640B | |
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | |
| -1.66% | +1.72% | +36.94% | +31.37% | 353B | |
| -1.27% | +0.28% | +34.73% | +40.57% | 301B | |
| -2.16% | +1.25% | +11.72% | +14.84% | 271B | |
| -1.35% | +4.00% | +2.49% | -39.00% | 228B | |
| -1.39% | +5.90% | +27.70% | +64.00% | 209B | |
| -1.18% | +1.83% | +16.20% | +72.69% | 165B | |
| Average | -0.92% | +3.47% | +26.43% | +39.45% | 370.98B | |
| Weighted average by Cap. | -1.18% | +4.86% | +41.38% | +77.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.27M 12.54M 11.7M 10.74M 20.1M 1.37B 20.6M 54.26M 676M 53.56M 52.4M 2.34B | 21.15M 2.17M 1.91M 1.78M 1.64M 3.06M 208M 3.14M 8.27M 103M 8.16M 7.99M 356M |
| Net income | 52.18M 5.36M 4.71M 4.4M 4.04M 7.56M 514M 7.75M 20.4M 254M 20.14M 19.7M 879M | -26.04M -2.68M -2.35M -2.2M -2.02M -3.77M -256M -3.87M -10.19M -127M -10.05M -9.84M -439M |
| Net Debt | -17.48M -1.8M -1.58M -1.47M -1.35M -2.53M -172M -2.59M -6.84M -85.19M -6.75M -6.6M -294M | 24.86M 2.56M 2.25M 2.1M 1.92M 3.6M 245M 3.69M 9.72M 121M 9.6M 9.39M 419M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | SEK 17.66 | +1.49% | 109,541 |
| 29/07/26 | SEK 17.40 | +1.40% | 195,104 |
| 28/07/26 | SEK 17.16 | -6.02% | 287,766 |
| 27/07/26 | SEK 18.26 | -1.19% | 97,909 |
| 24/07/26 | SEK 18.48 | -0.11% | 88,059 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Select your edition
All financial news and data tailored to specific country editions
